BIOMEA FUSION TO ANNOUNCE PHASE I RESULTS FOR BMF-650, ITS NEXT-GENERATION ORAL SMALL-MOLECULE GLP-1 RECEPTOR AGONIST

Reuters · 1d ago

Please log in to view news